ALEXANDRIA PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of AXPH for the last quarter is 511.08 M EGP, and it's 0.17% lower compared to the previous quarter. The net income of Q3 24 is 54.07 M EGP.